Skip to content

Improving the design of insoles for diabetic foot disease

Optimisation of custom insoles for pressure relief in patients with diabetes via finite element modelling

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN19805071
Enrollment
20
Registered
2015-08-21
Start date
2015-03-01
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes with peripheral neurpathy Nutritional, Metabolic, Endocrine Diabetes mellitus

Interventions

Three interventions are administered to each participant in a randomised, crossover fashion: 1. Standard, total contact insole with modifications for forefoot offloading (control). This is a tradition

Sponsors

Glasgow Caledonian University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 18-75 years of age 2. Shoe size 5-11 (UK) 3. Able to walk 300m (including ~20m barefoot) safely 4. Diabetes mellitus Type 1 or 2 with duration =10 years 5. Diabetic peripheral neuropathy defined as loss of sensation to 10g monofilament test at one or more forefoot sites 6. Elevated barefoot plantar pressure (>700kPa) measured at the forefoot during walking

Exclusion criteria

Exclusion criteria: 1. Lower limb, foot or digital amputation (at a level proximal to the distal IPJ, or involving the hallux) 2. Severe callus (callus will not result in exclusion if it has been reduced to a level that does not affect sensation of underlying skin) 3. History of medical conditions, injuries or surgical procedures that significantly influence gait, or which cause pain on walking (including Charcot) 4. Severe foot deformity or reduction in ROM that result in abnormal gait or preclude good fit of study shoe (including Charcot) 5. Severe concurrent medical condition that would prevent participation in study procedures (e.g. severe cardiac/pulmonary condition that precludes activity) or with life expectancy = 3 months. 6. Pregnancy

Design outcomes

Primary

MeasureTime frame
Forefoot peak plantar pressure, measured using an in-shoe plantar pressure measurement system (Pedar, Novel GmbH, Munich) at a single timepoint immediately after the insoles are provided to the patient

Secondary

MeasureTime frame
Validation of computational models in this patient population comparing the predicted plantar pressures to those measured experimentally

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 9, 2026